These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11792689)

  • 1. Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs.
    Sadowitz PD; Hubbard BA; Dabrowiak JC; Goodisman J; Tacka KA; Aktas MK; Cunningham MJ; Dubowy RL; Souid AK
    Drug Metab Dispos; 2002 Feb; 30(2):183-90. PubMed ID: 11792689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic study of the reaction of cisplatin with thiols.
    Dabrowiak JC; Goodisman J; Souid AK
    Drug Metab Dispos; 2002 Dec; 30(12):1378-84. PubMed ID: 12433807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
    Treskes M; Nijtmans LG; Fichtinger-Schepman AM; van der Vijgh WJ
    Biochem Pharmacol; 1992 Mar; 43(5):1013-9. PubMed ID: 1313234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T; Masuda H; Naito M; Tamai H
    Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental and theoretical studies on the pharmacodynamics of cisplatin in jurkat cells.
    Tacka KA; Szalda D; Souid AK; Goodisman J; Dabrowiak JC
    Chem Res Toxicol; 2004 Nov; 17(11):1434-44. PubMed ID: 15540941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
    Johnsson A; Olsson C; Nygren O; Nilsson M; Seiving B; Cavallin-Stahl E
    Cancer Chemother Pharmacol; 1995; 37(1-2):23-31. PubMed ID: 7497593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
    Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of the reactions of 4-hydroperoxycyclophosphamide and acrolein with glutathione, mesna, and WR-1065.
    Tacka KA; Dabrowiak JC; Goodisman J; Souid AK
    Drug Metab Dispos; 2002 Aug; 30(8):875-82. PubMed ID: 12124304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
    Meijer C; de Vries EG; Marmiroli P; Tredici G; Frattola L; Cavaletti G
    Neurotoxicology; 1999 Dec; 20(6):883-7. PubMed ID: 10693969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA.
    Los G; van Vugt MJ; den Engelse L; Pinedo HM
    Biochem Pharmacol; 1993 Oct; 46(7):1229-37. PubMed ID: 8216374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E; Groen HJ; Helder MN; de Vries EG; Meijer C
    Biochem Pharmacol; 2002 Jun; 63(11):1989-96. PubMed ID: 12093475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells.
    Chi KH; Kunugi KA; Kinsella TJ
    Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs.
    Ravera M; Gabano E; Zanellato I; Bonarrigo I; Alessio M; Arnesano F; Galliani A; Natile G; Osella D
    J Inorg Biochem; 2015 Sep; 150():1-8. PubMed ID: 26042542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adducts.
    Vendrik CP; Fichtinger-Schepman AM; van Dijk-Knijnenburg WC; de Jong WH; van der Minnen AC; de Groot G; Berends GF; Steerenberg PA
    Cancer Chemother Pharmacol; 1997; 39(6):479-85. PubMed ID: 9118458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
    Hettinga JV; Lemstra W; Meijer C; Dam WA; Uges DR; Konings AW; De Vries EG; Kampinga HH
    Br J Cancer; 1997; 75(12):1735-43. PubMed ID: 9192975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG
    Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF; Hunakova L; Kelland LR
    Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cytotoxicities of platinum compounds.
    Goodisman J; Hagrman D; Tacka KA; Souid AK
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts.
    De Pooter CM; Van Oosterom AT; Scalliet PG; Maes RA; de Bruijn EA
    Biochem Pharmacol; 1996 Mar; 51(5):629-34. PubMed ID: 8615899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy.
    Meijera C; van Luyn MJ; Nienhuis EF; Blom N; Mulder NH; de Vries EG
    Biochem Pharmacol; 2001 Mar; 61(5):573-8. PubMed ID: 11239500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.